P2.06-012 Phase 2 Study of Abemaciclib + Pembrolizumab in KRAS Mutation, PD-L1+, Stage IV Non-Small Cell or Squamous Cell Lung Cancer
2017 ◽
Vol 12
(1)
◽
pp. S1076-S1077
◽
Julien Mazieres
◽
Sara Tolaney
◽
Luis Paz-Ares
◽
Jean-Louis Pujol
◽
Tuncay Goksel
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS9101-TPS9101
Giorgio V. Scagliotti
◽
Ramaswamy Govindan
◽
Karla Hurt
◽
Alan Chiang
Taofeek K. Owonikoko
◽
Mary W. Redman
◽
Lauren A. Byers
◽
Fred R. Hirsch
◽
Philip C. Mack
◽
...
Sam Janes
◽
Laura Succony
2021 ◽
Vol 16
(3)
◽
pp. S651-S652
J. Beal
◽
D. Gomes
◽
P. Taranto
◽
L. Koch
◽
A.C. Rezende
◽
...
Ying Cheng
◽
Qiming Wang
◽
Kai Li
◽
Jianhua Shi
◽
Ying Liu
◽
...
2019 ◽
Vol 14
(10)
◽
pp. S646
◽
C. Ocampo
◽
J. Wu
◽
J. Dey
◽
Z. Sun
◽
M. Motwani
◽
...
2012 ◽
Vol 76
(1)
◽
pp. 78-83
◽
Benjamin Besse
◽
David Planchard
◽
Anne-Sophie Veillard
◽
Laurent Taillade
◽
David Khayat
◽
...
2015 ◽
Vol 93
(4)
◽
pp. 757-764
◽
Gregory M.M. Videtic
◽
Chen Hu
◽
Anurag K. Singh
◽
Joe Y. Chang
◽
William Parker
◽
...
Bo Qiu
◽
DaQuan Wang
◽
QiWen Li
◽
YingJia Wu
◽
SuPing Guo
◽
...